| Age: median (IQR) | 2 years (1–5) |
| Gender (male) | 94 (57%) |
| Subtype - A | 112 (68%) |
| Subtype - B | 49 (30%) |
| Subtype - A + B | 2 (1%) |
| not known | 3 (2%) |
| Hospital stay: median (IQR) | 2 days (2–4) |
| Paediatric intensive care unit (PICU) | 9 (5%) |
| Hospital stay on PICU: median (IQR) | 6 days (3–8) |
| Antibiotics on PICU | 8 (89% of PICU patients) |
| Invasive ventilation | 2 (1%) |
| Non-invasive ventilation | 2 (1%) |
| Oxygen therapy | 10 (6%) |
| Max. CRP (mg/l): median (IQR) | 8.2 (2.95–21.20) |
| Leukocytes (G/l): median (IQR) | 7.3 (5.4–10.6) |
| Antibiotics before admission | 16 (10%) |
| Antibiotics on ward | 38 (24%) |
| Deaths | 1 (1%) |
| Vaccinated | 1 out of 166 |
